v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 30,321 $ 50,501
Accounts receivable 3,563 926
Contract assets and unbilled receivables (Note 10) 2,209 1,407
Prepaids and other current assets 515 1,099
Short-term investments 2 15
Total current assets 36,610 53,948
Property and equipment, net 252 0
Total assets 36,862 53,948
Current liabilities:    
Accounts payable 3,148 2,153
Accrued expenses 8,145 1,815
Derivative liability 2 74
Total current liabilities 11,295 4,042
Total liabilities 11,295 4,042
Commitments and contingencies (Note 3 and Note 9)
Series A preferred stock, par value $0.0001; 14,146 shares and no shares were designated as of December 31, 2024 and 2023, respectively; 14,145.374 and no shares issued and outstanding at December 31, 2024 and 2023, respectively. 18,843 0
Stockholders' equity:    
Preferred stock, par value $0.0001; 9,985,854 and 10,000,000 shares authorized as of December 31, 2024 and 2023, respectively; no shares issued and outstanding at December 31, 2024 and 2023. 0 0
Common stock, par value $0.0001; 125,000,000 and 75,000,000 shares authorized as of December 31, 2024 and 2023, respectively; 31,574,657 and 23,977,491 shares issued and outstanding at December 31, 2024 and 2023, respectively. 3 2
Additional paid-in capital 145,719 131,370
Accumulated deficit (138,998) (81,466)
Total stockholders' equity 6,724 49,906
Total liabilities, series A preferred stock, and stockholders' equity $ 36,862 $ 53,948

Source